Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis (AS) and Inadequate Response to ≥2 Nonsteroidal Antiinflammatory Drug (NSAID)

NCT01091675 is registered in ClinicalTrials.gov with Spanish Foundation of Rheumatology as lead sponsor.

NCT NCT01091675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01091675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis (AS) and Inadequate Response to ≥2 Nonsteroidal Antiinflammatory Drug (NSAID)
Lead sponsor
Spanish Foundation of Rheumatology
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
May 31, 2013
Enrollment
58 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis